Shire headache for FTSE

clock

Having charged across the 5,000 mark yesterday, the FTSE 100 index has shed a couple of points this morning to 4,987.7, paced by Shire Pharmaceuticals Group.

Drugmaker Shire has fallen 60.5p or as much as 9.5% to 581.50p, after Canadian regulators ordered the company to withdraw its biggest selling drug, Adderall XR, as a result of its link to at least 20 deaths. Barclays bank has also dropped 14p to 580p in morning trading even though the lender posted a 14% increase in second-half profit as investment-banking income rose and loan loss provisions declined. Imperial Chemical Industries meanwhile has gained 20.50p or 8% to 266.50p. In Japan the Nikkei 225 Stock Average raced to a seven-month high, advancing 0.7% to 11,553.56 at its close ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Trian and General Catalyst to purchase Janus Henderson for $7.4bn

Trian and General Catalyst to purchase Janus Henderson for $7.4bn

Will continue to be led by current management team

Patrick Brusnahan
clock 23 December 2025 • 2 min read
2025 reflections: How strong companies trumped politics

2025 reflections: How strong companies trumped politics

Fears of an AI market bubble persist

Ryan Hughes
clock 23 December 2025 • 3 min read
What does 2026 hold for investment?

What does 2026 hold for investment?

‘The disruptors of yesterday are now the establishment’

Jen Frost
clock 17 December 2025 • 3 min read